Company Overview - Yangmei Biotechnology (Chengdu) Co., Ltd. is a medical health enterprise established in 2016, focusing on the research, production, and commercialization of regenerative medical devices and special medical foods [3] - The company specializes in the development, transformation, and application of regenerative medical materials, as well as the research and development of specific full-nutrition formula foods [3] - Yangmei Biotechnology has accumulated key technologies in the fields of polymer materials and regenerative biomaterials, including research, modification, preparation, and the development of microspheres [3] Product Lines - The company has a strong product portfolio that includes two main product lines: regenerative medical material injectables and medical dressings and patches [3] - As of May 5, 2025, the company has 13 candidate products for regenerative medical material injectables, including core product XH301 and candidate product XH321 for treating female stress urinary incontinence, with two products already in the registration review stage [4] - In the medical dressings and patches product line, seven products have obtained second-class medical device registration approval, and one candidate product XH322 for breast reconstruction post-breast cancer surgery is in the preclinical stage [4] - The special medical food product line includes two products approved by the National Medical Products Administration and seven candidate products under development [4] Financial Performance - The company's revenue for 2023 and 2024 is projected to be RMB 12.88 million and RMB 14.52 million, respectively [5] - The total loss for the same periods is expected to be RMB 63.50 million and RMB 69.38 million, indicating ongoing financial challenges [5] - Gross profit for 2023 is RMB 1.47 million, which decreases to RMB 0.38 million in 2024, reflecting a decline in profitability [5]

相关医疗机构和特医食品企业从特医食品临床管理实践、医疗机构医用食品运营解决方案、临床营养与 医学食品服务体系信息化建设等角度进行了介绍。朝阳区市场监管局向在场的医疗机构开展了特殊医学 用途配方食品医院备案制政策解读和法规培训。 特医食品是指为满足进食受限、消化吸收障碍、代谢紊乱或者特定疾病状态人群对营养素或者膳食的特 殊需要，专门加工配制而成的配方食品。上海交通大学医学院附属新华医院教授、上海市儿科医学研究 所所长蔡威表示，特医食品虽然其名字带有"食品"字样，但对于多种罕见病的治疗来说，可以说是"救 命药"。在我国207种罕见病目录中，有32种需使用特医食品。虽然特医食品在中国具有巨大的市场需 求，但进入医院面临诸多困难，严重阻碍行业发展。目前，我国特医食品研发供给存在产品供给有限、 研发投入有限、销售途径有限等问题。 桓兴肿瘤医院营养科主任姚克青介绍，肿瘤患者营养不良、低蛋白血症发病率高，增加医疗费用，增加 并发症发生率，影响患者预后。对于低蛋白血症患者，临床医生经常使用人血白蛋白制剂，但人血白蛋 白为血液制剂，也是国家第二批国家重点监控药品，临床使用适应证严格，价格较贵，每10克人血白蛋 白为400-50 ...